Takeyoshi Yamashita
Chief Tech/Sci/R&D Officer bij KYOWA KIRIN CO. LTD.
Profiel
Takeyoshi Yamashita currently works at Kyowa Kirin Co., Ltd., as Director & Chief Medical Officer from 2023 and Orchard Therapeutics Plc, as Director from 2024.
Actieve functies van Takeyoshi Yamashita
Bedrijven | Functie | Begin |
---|---|---|
KYOWA KIRIN CO. LTD. | Chief Tech/Sci/R&D Officer | 01-04-2023 |
ORCHARD THERAPEUTICS PLC | Director/Board Member | 24-01-2024 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
KYOWA KIRIN CO. LTD. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Orchard Therapeutics Plc
Orchard Therapeutics Plc Pharmaceuticals: MajorHealth Technology Orchard Therapeutics Plc is a biopharmaceutical company, which engages in discovering, acquiring, developing and commercializing gene therapies for patients with rare disorders. The company focuses on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies. Its portfolio includes Strimvelis, a commercial-stage gamma retroviral-based product for the treatment of Adenosine deaminase deficiency (ADA-SCID). The company was founded by Nicolas Koebel and Andrea Spezzi in August 2018 and is headquartered in London, the United Kingdom. | Health Technology |